Cargando…
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982277/ https://www.ncbi.nlm.nih.gov/pubmed/36875900 http://dx.doi.org/10.1016/j.jaccao.2022.10.012 |
_version_ | 1784900295274266624 |
---|---|
author | Mohan Singh Sindhi, Rithik Ahmad, Mahmood |
author_facet | Mohan Singh Sindhi, Rithik Ahmad, Mahmood |
author_sort | Mohan Singh Sindhi, Rithik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9982277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99822772023-03-04 Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy Mohan Singh Sindhi, Rithik Ahmad, Mahmood JACC CardioOncol Letter to the Editor Elsevier 2023-02-21 /pmc/articles/PMC9982277/ /pubmed/36875900 http://dx.doi.org/10.1016/j.jaccao.2022.10.012 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Letter to the Editor Mohan Singh Sindhi, Rithik Ahmad, Mahmood Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy |
title | Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy |
title_full | Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy |
title_fullStr | Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy |
title_full_unstemmed | Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy |
title_short | Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy |
title_sort | novel technologies must be considered for childhood cancer survivors at risk for cardiomyopathy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982277/ https://www.ncbi.nlm.nih.gov/pubmed/36875900 http://dx.doi.org/10.1016/j.jaccao.2022.10.012 |
work_keys_str_mv | AT mohansinghsindhirithik noveltechnologiesmustbeconsideredforchildhoodcancersurvivorsatriskforcardiomyopathy AT ahmadmahmood noveltechnologiesmustbeconsideredforchildhoodcancersurvivorsatriskforcardiomyopathy |